Eva Gonzalez-Suarez lab

Our new graphical abstract. Thanks @ESEndocrinology for the opportunity to present our work. Great meeting. If you miss the talk and poster, you can read the original manuscript doi.org/10.1126/scienc…

@Alej_Collado @ESEndocrinology @CNIOStopCancer Great opportunity to present our just published work at @ScienceMagazine to the @ESEndocrinology at #ECE2026. Congrats @Alej_Collado

Big thanks to the @ESEndocrinology for giving me the opportunity to present my poster about the role of microglia RANK signaling in control of fertility. Work in @EGlezSuarezlab in @CNIOStopCancer

@ESEndocrinology Tomorrow I will present in this room to the audience of @ESEndocrinology the work done by @Alej_Collado and collaborators at @CNIOStopCancer about #microglia and #HPG axis.

Today, we celebrate 20 years of ESE at 14:50 at #ECE2026! A special occasion to reflect on two decades of dedication to endocrinology and what lies ahead. Take photos at our photo wall at Forum Foyer 2 and share on social media. See our photo gallery. 👉ow.ly/8OmN50YXxgt

Quite an impressive room for my first talk at @ESEndocrinology. Fantastic venue and organization

First time at the @European Congress of Endocrinology 2026. Such an impressive meeting. Happy to celebrate with Manolo Tena Sempere

@_TheTransmitter has published a commentary about our article on #microglia and #fertility recently published in @ScienceMagazine. Check It out: urldefense.com/v3/__https://w…$

@hepaticcellnews @NabilDjouder @NatMetabolism @CNIOStopCancer Congrats Nabil and team

📢 New in @NatMetabolism! Reserchers led by Dr. @NabilDjouder at @CNIOStopCancer have shown that biliary epithelial cells protect against #LiverFibrosis by maintaining duct integrity through FXR–YAP signaling, which prevents bile acid-induced damage. Learn more: go.nature.com/3QPoa3p

Registration closes on May 3rd! Hurry up #mammary #breastcancer. #GordonConference grc.org/mammary-gland-…

Hurry Up! Registration closes on May 3! You cannot miss the opportunity to join us in Italy urldefense.com/v3/__https:/li…$

Great to see that a News & Views article has now highlighted our recent study @NatMetabolism , emphasizing the role of FXR signaling in biliary epithelial cells as an active protective barrier, rather than simply passive bile duct conduits nature.com/articles/s4225…

@Gsabiolab @CNIOStopCancer @CNIC_CARDIO @CintiaFolgueira @lorealspain Congrats!

Hoy es un día muy muy feliz para mi. Que orgullo ver como una gran investigadora que se han formado en mi lab @CNIOStopCancer @CNIC_CARDIO despegan por si mismas y triunfan. @CintiaFolgueira Premio for women in Science Loreal-Unesco. @lorealspain. Enhorabuena Cintia muy merecido!

Contenta de dar difusión a este descubrimiento de @CNIOStopCancer e @idibell_cat mhttps://www.lasexta.com/tecnologia-tecnoxplora/sinc/encuentran-marcador-que-identifica-lesiones-precancerosas-mama-que-convertiran-tumores_2026041769e208e6b7e0a27eb99b517c.html

🔬‼️ When brain metastases appear could be a key factor in the survival of patients with advanced #breastcancer 🧠 🧪 A new subgroup analysis from the @GEICAM RegistEM study, recently published in the journal Therapeutic Advances in Medical Oncology, provides real-world evidence on how central nervous system involvement (#CNS) impacts clinical outcomes. 📊 From the study, which analyzed 1,947 women with advanced breast cancer, it was found that 18% developed brain metastases. Of these, 25% already had CNS involvement at the time of diagnosis, with a median #survival of 26 months, compared to only 9 months in those who developed metastases during the disease. 🧬 Relevant differences were also observed according to subtype. #HER2+ and triple-negative tumors were the most likely to develop brain metastases early. In particular, patients with #triplenegative breast cancer showed the worst survival, with a median of just 6 months after the diagnosis of brain metastases. 💡 These results reinforce the importance of having therapies with intracranial activity, especially in higher-risk subgroups, and highlight the need to advance strategies for the prevention and management of #metastases in the CNS. 💜 Thank you to all the authors, researchers, and collaborating centre teams for this important work! 📝 The full press release is available below for more information: ➡️ geicam.org/wp-content/upl…

Thank you for the opportunity to present our work! I presented our paper on microglia Rank signaling controlling the HPG axis, published last month in @ScienceMagazine This research was carried out in the lab of @EGlezSuarezlab in @CNIOStopCancer #CajaIConference #Neuroscience

@PujanaLab @ElizSMcKenna @CD_AACR @BrunetJbrunet @antonis02 @idibell_cat @idibgi @ICO_oncologia Congrats!

Happy to share our perspective on cancer precision prevention, honored to be published in @CD_AACR collab with @BrunetJbrunet & Antonis C Antoniou @antonis02 @idibell_cat @idibgi @ICO_oncologia Advancing Cancer Prevention through Precision Prediction aacrjournals.org/cancerdiscover…

Contenta de la difusión en la prensa local del hallazgo publicado en @ScienceMagazine y de la buena formación recibida en la @uniovi_info, que fue el inicio de mi carrera investigadora acrobat.adobe.com/id/urn:aaid:sc…

Una nanopartícula desarrollada en la UPV abre una nueva vía contra el cáncer consalud.es/profesionales/…

🧬 Un estudio liderado por la investigadora de nuestra red Eva González-Suárez (CNIO) revela que el “interruptor” de la pubertad y la capacidad reproductiva no está en los órganos sexuales, sino en las células inmunitarias del cerebro. tinyurl.com/c4b87vym